Mar-Afatinib 20 mg

Afatinib (afatinib dimaleate) 20 mg tablets are a targeted therapy used to treat certain types of cancer. This oral medication is designed to inhibit specific proteins involved in cancer cell growth.

Afatinib is primarily used in the treatment of non-small cell lung cancer (NSCLC) and other advanced cancers. It works by targeting and blocking proteins that promote cancer cell growth, helping to slow down the progression of the disease. Patients often wonder, 'What is afatinib used for?' This medication is typically prescribed for conditions where these proteins are overactive.

Common effects of afatinib may include skin reactions, diarrhea, and appetite loss. Some users also report fatigue and nausea. These effects can vary widely among individuals and may not affect everyone who takes the medication.

Afatinib should be handled with care, especially regarding potential interactions with other medications. It is important to follow the advice of a healthcare provider when starting or adjusting the dosage. Patients should also be aware of potential side effects and report any severe reactions promptly.

Afatinib may interact with certain medications, including those that affect liver enzymes. It is advisable to consult a healthcare provider before combining afatinib with other treatments. Alcohol and certain supplements may also impact the effectiveness of afatinib.